GLPwatch
The role of combination therapy in type 2 diabetes in the post-ACCORD era.
Curr Diab Rep · 2012
Last updated 2026-05-28| Journal | Curr Diab Rep, 2012 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 22528598 ↗